Skip to main content
Jennifer Juhl Majersik
( out of 34 reviews )

Jennifer Juhl Majersik, MD, MS

Languages spoken: English

Clinical Locations

Clinical Neurosciences Center

Salt Lake City
801-585-7575
  • Dr. Majersik is a Professor of Neurology at the University of Utah, School of Medicine. After receiving her B.S. in Physics from Harvey Mudd College (Claremont, CA), she served in the Air Force as a Scientific Analyst at Wright-Patterson Air Force Base National Air Intelligence Center. In 1997, she attended medical school at University of Vermont (Burlington, VT) where she fell in love with the neurosciences. She completed internship and neurology residency at the University of Utah and then decided to seek additional expertise in stroke by completing a vascular neurology fellowship at University of Michigan (Ann Arbor, MI). While at Michigan, she earned a master's degree in clinical research design and biostatistics through their School of Public Health.

    In 2008, Dr. Majersik returned to Salt Lake City to establish her vascular neurology practice within the Stroke Center at the University of Utah. Her clinical practice includes evaluating and treating acute strokes in the hospital and emergency department, managing patients on the inpatient general neurology service, and providing outpatient consultation in the stroke clinic, including urgent referrals. She has a particular interest in rare single gene disorders causing stroke (such as CADASIL), hypercoaguable states (such as Antiphospholipid Antibody Syndrome), and vascular malformations (such as cavernous malformations and hereditary hemorrhagic telangiectasias). She also provides emergency consultation to stroke patients at community hospitals via the telestroke network.

    In 2010, she became Director of the University of Utah Stroke Center. Dr. Majersik is currently studying the genetic underpinnings of stroke in large families in Utah and more common polygenetic disorders leading to increased risk of stroke as well as conducting a study on motor recovery after stroke.

    She lives here in Salt Lake City and enjoys hiking the mountains and raising her family.

    Board Certification

    American Board of Psychiatry & Neurology (Neurology)
    American Board of Psychiatry & Neurology (Sub: Vascular Neurology)

    Patient Rating

    4.9 /5
    ( out of 34 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    May 01, 2024
    CLINICAL NEUROSCIENCES CENTER

    She was very very nice and great to talk with her

    May 01, 2024
    CLINICAL NEUROSCIENCES CENTER

    In my opinion, Dr. Majersik is A-1 superior in the field of neurology and is equally deserving of a +10 rating. To further, she always goes a step or more further in assuring that I get the care and attention deserved. As an example, before I even got home, I received a call from a Medicare/Medicaid Assistant to readily assist me with applying for all the services needed. I truly respect Dr. Majersik for her knowledge and true care and concern for her patients. THANK YOU, DR. MAJERSIK!

    April 24, 2024
    CLINICAL NEUROSCIENCES CENTER

    Great doctor and wonderful to work with!

    February 23, 2024
    CLINICAL NEUROSCIENCES CENTER

    Dr. Majersik is wonderful. She is very friendly and interested in her patients lives and health. She was very calm and kind. She let me ask any questions I wanted and made me feel relaxed and devoted her time to me. She was knowledgeable, thoughtful about decisions, and explained things well. She's a fantastic doctor and I highly recommend her.

    January 30, 2024
    CLINICAL NEUROSCIENCES CENTER

    Dr. Majersik truly cares about what patients think. She is kind and compassionate. She makes sure to review my medications with me so I understand any potential side effects and she makes sure all dosages are correct.

    October 04, 2023
    CLINICAL NEUROSCIENCES CENTER

    As previously stated Dr Majersik took time without rushing to answer all my questions and concerns. She is a very caring and empathetic physician

    August 18, 2023
    CLINICAL NEUROSCIENCES CENTER

    Extremely goid.

    August 17, 2023
    CLINICAL NEUROSCIENCES CENTER

    She listened to me about potential benefits from changes in my medications and was open to my suggestions. I have been a nurse for 46 years and she did made me feel listened to and acknowledged what I had researched.

    August 13, 2023
    CLINICAL NEUROSCIENCES CENTER

    She listened and was very kind to look for the reason why I was where I was

  • Dr. Majersik is a Professor of Neurology at the University of Utah, School of Medicine. After receiving her B.S. in Physics from Harvey Mudd College (Claremont, CA), she served in the Air Force as a Scientific Analyst at Wright-Patterson Air Force Base National Air Intelligence Center. In 1997, she attended medical school at University of Vermont (Burlington, VT) where she fell in love with the neurosciences. She completed internship and neurology residency at the University of Utah and then decided to seek additional expertise in stroke by completing a vascular neurology fellowship at University of Michigan (Ann Arbor, MI). While at Michigan, she earned a master's degree in clinical research design and biostatistics through their School of Public Health.

    In 2008, Dr. Majersik returned to Salt Lake City to establish her vascular neurology practice within the Stroke Center at the University of Utah. Her clinical practice includes evaluating and treating acute strokes in the hospital and emergency department, managing patients on the inpatient general neurology service, and providing outpatient consultation in the stroke clinic, including urgent referrals. She has a particular interest in rare single gene disorders causing stroke (such as CADASIL), hypercoaguable states (such as Antiphospholipid Antibody Syndrome), and vascular malformations (such as cavernous malformations and hereditary hemorrhagic telangiectasias). She also provides emergency consultation to stroke patients at community hospitals via the telestroke network.

    In 2010, she became Director of the University of Utah Stroke Center. Dr. Majersik is currently studying the genetic underpinnings of stroke in large families in Utah and more common polygenetic disorders leading to increased risk of stroke as well as conducting a study on motor recovery after stroke.

    She lives here in Salt Lake City and enjoys hiking the mountains and raising her family.

    Board Certification and Academic Information

    Academic Departments Neurology -Primary
    Board Certification
    American Board of Psychiatry & Neurology (Neurology)
    American Board of Psychiatry & Neurology (Sub: Vascular Neurology)

    Education history

    Graduate Training Clinical Research/Stat Aly - University of Michigan M.S.
    Vascular Neurology - University of Michigan Fellow
    Residency Neurology - University of Utah School of Medicine Resident
    Internal Medicine - University of Utah School of Medicine Intern
    Professional Medical Medicine - University of Vermont College of Medicine M.D.
    Physics - Harvey Mudd College B.S.

    Selected Publications

    Journal Article

    1. Karen C Schliep, C Elizabeth Shaaban, Huong Meeks, Alison Fraser, Ken R Smith, Jennifer J Majersik, Norman L Foster, Jean Wactawski-Wende, Truls stbye, JoAnn Tschanz, James F Padbury, Surrendra Sharma, Yue Zhang, Julio C Facelli, C Samir Abdelrahman, Lauren Theilen, Michael W Varner (2023). Hypertensive disorders of pregnancy and subsequent risk of Alzheimer's disease and other dementias. Alzheimer's Association.
    2. de Havenon A, Orlando C, Delic A, McNally JS, Majersik JJ, Harman T, Alexander M, Reddy V, Lyden S, Anzai Y (2022). Direct cost analysis of rapid MRI in the emergency department evaluation of patients suspected of having acute ischemic stroke*. Neuroradiol J, 36(2), 142-147. (Read full article)
    3. Wong KH, Muddasani V, Peterson C, Sheibani N, Arkin C, Cheong I, Majersik JJ, Biffi A, Petersen N, Falcone GJ, Sansing LH, de Havenon AH (2022). Baseline Serum Biomarkers of Inflammation and Subsequent Visit-to-Visit Blood Pressure Variability: A Post Hoc Analysis of MESA. Am J Hypertens, 36(3), 144-147. (Read full article)
    4. Nakamoto CH, Wilcock AD, Schwamm LH, Majersik JJ, Zachrison KS, Mehrotra A (2022). Trends in characteristics of neurologists who provide stroke consultations in the USA, 2008-2021. Stroke Vasc Neurol, 8(1), 86-88. (Read full article)
    5. Goldstein ED, Gopal N, Badi MK, Hodge DO, de Havenon A, Glover P, Durham PL, Huang JF, Lin MP, Baradaran H, Majersik JJ, Meschia JF (2022). CGRP, Migraine, and Brain MRI in CADASIL: A Pilot Study. Neurologist. (Read full article)
    6. Einerson J, Cardell B, Majersik JJ, Reblin M, Richards LG, Terrill AL (2022). Piloting GETCare: A Goal-Based Education and Skills Training Program for Caregivers. Rehabil Nurs, 47(6), 220-227. (Read full article)
    7. Garcia-Esperon C, Bladin CF, Kleinig TJ, Brown H, Majersik JJ, Wesseldine A, Butcher K (2022). The acute telestroke model of care in Australia: a potential roadmap for other emergency medical services? Med J Aust, 216(10), 498-500. (Read full article)
    8. Denorme F, Portier I, Rustad JL, Cody MJ, de Araujo CV, Hoki C, Alexander MD, Grandhi R, Dyer MR, Neal MD, Majersik JJ, Yost CC, Campbell RA (2021). Neutrophil extracellular traps regulate ischemic stroke brain injury. J Clin Invest, 132(10). (Read full article)
    9. Kashida YT, Lillicrap T, Walker R, Holliday E, Hasnain MG, Tomari S, Garcia-Esperon C, Majersik JJ, Spratt NJ, Levi C (2022). Transition in Incidence Rate of Hospitalised Stroke and Case Fatality Rate in the Hunter Region, Australia, 2001-2019: A Prospective Hospital-Based Study. J Stroke Cerebrovasc Dis, 31(4), 106266. (Read full article)
    10. Wilcock AD, Schwamm LH, Zubizarreta JR, Zachrison KS, Uscher-Pines L, Majersik JJ, Richard JV, Mehrotra A (2022). Legislation Increased Medicare Telestroke Billing, But Underbilling And Erroneous Billing Remain Common. Health Aff (Millwood), 41(3), 350-359. (Read full article)
    11. Terrill AL, Reblin M, MacKenzie JJ, Baucom BRW, Einerson J, Cardell B, Richards LG, Majersik JJ (2022). Intimate Relationships and Stroke: Piloting a Dyadic Intervention to Improve Depression. Int J Environ Res Public Health, 19(3). (Read full article)
    12. de Havenon A, Sheth K, Johnston KC, Delic A, Stulberg E, Majersik J, Anadani M, Yaghi S, Tirschwell D, Ney J (2021). Acute Ischemic Stroke Interventions in the United States and Racial, Socioeconomic, and Geographic Disparities. Neurology, 97(23), e2292-e2303. (Read full article)
    13. de Havenon A, Delic A, Yaghi S, Wong KH, Majersik JJ, Stulberg E, Tirschwell D, Anadani M (2020). Midlife Blood Pressure Variability and Risk of All-Cause Mortality and Cardiovascular Events During Extended Follow-up. Am J Hypertens, 34(12), 1269-1275. (Read full article)
    14. Kim H, Flemming KD, Nelson JA, Lui A, Majersik JJ, Cruz MD, Zabramski J, Trevizo O, Lanzino G, Zafar A, Torbey M, Mabray MC, Robinson M, Narvid J, Lupo J, Thompson RE, Hanley DF Jr, McBee N, Treine K, Ostapkovich N, Stadnik A, Piedad K, Hobson N, Carroll T, Shkoukani A, Carrin-Penagos J, Mendoza-Puccini C, Koenig JI, Awad I (2021). Baseline Characteristics of Patients With Cavernous Angiomas With Symptomatic Hemorrhage in Multisite Trial Readiness Project. Stroke, 52(12), 3829-3838. (Read full article)
    15. Khnlein P, Mahnkopf C, Majersik JJ, Wilson BD, Mitlacher M, Tirschwell D, Longstreth WT Jr, Akoum N (2021). Atrial fibrosis in embolic stroke of undetermined source: A multicenter study. Eur J Neurol, 28(11), 3634-3639. (Read full article)
    16. Ken-Dror G, Cotlarciuc I, Martinelli I, Grandone E, Hiltunen S, Lindgren E, Margaglione M, Duchez VLC, Triquenot AB, Zedde M, Mancuso M, Ruigrok YM, Marjot T, Worrall B, Majersik JJ, Metso TM, Putaala J, Haapaniemi E, Zuurbier SM, Brouwer MC, Passamonti SM, Abbattista M, Bucciarelli P, Mitchell BD, Kittner SJ, Lemmens R, Jern C, Pappalardo E, Costa P, Colombi M, de Sousa DA, Rodrigues S, Canho P, Tkach A, Santacroce R, Favuzzi G, Arauz A, Colaizzo D, Spengos K, Hodge A, Ditta R, Pezzini A, Debette S, Coutinho JM, Thijs V, Jood K, Pare G, Tatlisumak T, Ferro JM, Sharma P (2021). Genome-Wide Association Study Identifies First Locus Associated with Susceptibility to Cerebral Venous Thrombosis. Ann Neurol, 90(5), 777-788. (Read full article)
    17. Bossart A, McClune B, Barrell K, Warner J, Majersik JJ (2021). Pearls & Oy-sters: POEMS Syndrome: An Eloquent Acronym for a Rare Disease You Don't Want to Miss. Neurology, 97(17), 835-838. (Read full article)
    18. Baradaran H, Delic A, McNally JS, Alexander M, Majersik JJ, Parker DL, de Havenon A (2021). Carotid Compliance and Parahippocampal and Hippocampal Volume over a 20-Year Period. Dement Geriatr Cogn Dis Extra, 11(3), 227-234. (Read full article)
    19. Debette S, Mazighi M, Bijlenga P, Pezzini A, Koga M, Bersano A, Krv J, Haemmerli J, Canavero I, Tekiela P, Miwa K, J Seiffge D, Schilling S, Lal A, Arnold M, Markus HS, Engelter ST, Majersik JJ (2021). ESO guideline for the management of extracranial and intracranial artery dissection. Eur Stroke J, 6(3), XXXIX-LXXXVIII. (Read full article)
    20. de Havenon A, Tirschwell DL, Heitsch L, Cramer SC, Braun R, Cole J, Reddy V, Majersik JJ, Lindgren A, Worrall BB (2020). Variability of the Modified Rankin Scale Score Between Day 90 and 1 Year After Ischemic Stroke. Neurol Clin Pract, 11(3), e239-e244. (Read full article)
    21. de Havenon A, Ney JP, Callaghan B, Hohmann S, Shippey E, Yaghi S, Anadani M, Majersik JJ (2021). Characteristics and Outcomes Among US Patients Hospitalized for Ischemic Stroke Before vs During the COVID-19 Pandemic. JAMA Netw Open, 4(5), e2110314. (Read full article)
    22. Majersik JJ, Ahmed A, Chen IA, Shill H, Hanes GP, Pelak VS, Hopp JL, Omuro A, Kluger B, Leslie-Mazwi T (2021). A Shortage of Neurologists We Must Act Now: A Report From the AAN 2019 Transforming Leaders Program. Neurology, 96(24). (Read full article)
    23. Ravindra VM, Grandhi R, Delic A, Hohmann S, Shippey E, Tirschwell D, Frontera JA, Yaghi S, Majersik JJ, Anadani M, de Havenon A (2021). Impact of COVID-19 on the hospitalization, treatment, and outcomes of intracerebral and subarachnoid hemorrhage in the United States. PLoS One, 16(4), e0248728. (Read full article)
    24. Kashida YT, Garcia-Esperon C, Lillicrap T, Miteff F, Garcia-Bermejo P, Gangadharan S, Chew BLA, OBrien W, Evans J, Alanati K, Bivard A, Parsons M, Majersik JJ, Spratt NJ, Levi C, members of Northern NSW Telestroke investigators for this project (2021). The Need for Structured Strategies to Improve Stroke Care in a Rural Telestroke Network in Northern New South Wales, Australia: An Observational Study. Front Neurol, 12, 645088. (Read full article)
    25. Lindgren A, Braun R, Majersik JJ, Clatworthy P, Mainali S, Derdeyn CP, Maguire JM, Jern C, Rosand J, Cole JW, Lee JM, Khatri P, Nyquist PA, Debette SP, Keat Wei L, Rundek T, Leifer D, Thijs V, Lemmens R, Heitsch L, Prasad K, Jimenez-Conde J, Dichgans M, Rost NS, Cramer SC, Bernhardt J, Worrall BB, Cadenas I (2021). EXPRESS: International Stroke Genetics Consortium Recommendations for Studies of Genetics of Stroke Outcome and Recovery. Int J Stroke, 17474930211007288. (Read full article)
    26. Bailey RR, Singleton JR, Majersik JJ (2020). Association of obesity and diabetes with physical activity and fruit and vegetable consumption in stroke survivors. Fam Pract, 38(1), 56-61. (Read full article)
    27. Poon JT, Tkach A, Havenon AH, Hoversten K, Johnson J, Hannon PM, Chung LS, Majersik JJ (2021). Telestroke consultation can accurately diagnose ischemic stroke mimics. J Telemed Telecare, 1357633X21989558. (Read full article)
    28. de Havenon A, Ney JP, Callaghan B, Delic A, Hohmann S, Shippey E, Esper GJ, Stulberg E, Tirschwell D, Frontera J, Yaghi S, Anadani M, Majersik JJ (2020). Impact of COVID-19 on Outcomes in Ischemic Stroke Patients in the United States. J Stroke Cerebrovasc Dis, 30(2), 105535. (Read full article)
    29. Baradaran H, Delic A, Wong KH, Sheibani N, Alexander M, McNally JS, Majersik JJ, De Havenon A (2021). Using Ultrasound and Inflammation to Improve Prediction of Ischemic Stroke: A Secondary Analysis of the Multi-Ethnic Study of Atherosclerosis. Cerebrovasc Dis Extra, 11(1), 37-43. (Read full article)
    30. Wong KH, Hu K, Peterson C, Sheibani N, Tsivgoulis G, Majersik JJ, de Havenon AH (2020). Diabetic Retinopathy and Risk of Stroke: A Secondary Analysis of the ACCORD Eye Study. Stroke, 51(12), 3733-3736. (Read full article)
    31. Goldstein ED, Shakoor A, Majersik JJ (2020). Branch Retinal Vein Occlusion and Venous Abnormalities in CADASIL. Neurologist, 25(6), 178-179. (Read full article)
    32. Zha AM, Chung LS, Song SS, Majersik JJ, Jagolino-Cole AL (2020). Training in Neurology: Adoption of resident teleneurology training in the wake of COVID-19: Telemedicine crash course. Neurology, 95(9), 404-407. (Read full article)
    33. Leira EC, Russman AN, Biller J, Brown DL, Bushnell CD, Caso V, Chamorro A, Creutzfeldt CJ, Cruz-Flores S, Elkind MSV, Fayad P, Froehler MT, Goldstein LB, Gonzales NR, Kaskie B, Khatri P, Livesay S, Liebeskind DS, Majersik JJ, Moheet AM, Romano JG, Sanossian N, Sansing LH, Silver B, Simpkins AN, Smith W, Tirschwell DL, Wang DZ, Yavagal DR, Worrall BB (2020). Preserving stroke care during the COVID-19 pandemic: Potential issues and solutions. Neurology, 95(3), 124-133. (Read full article)
    34. Goldstein ED, Majersik JJ, McNally S (2020). Intracranial high-resolution vessel wall imaging in CADASIL. Neurology, 94(23), 1040-1041. (Read full article)
    35. Traenka C, Grond-Ginsbach C, Goeggel Simonetti B, Metso TM, Debette S, Pezzini A, Kloss M, Majersik JJ, Southerland AM, Leys D, Baumgartner R, Caso V, Bjot Y, De Marchis GM, Fischer U, Polymeris A, Sarikaya H, Thijs V, Worrall BB, Bersano A, Brandt T, Gensicke H, Bonati LH, Touze E, Martin JJ, Chabriat H, Tatlisumak T, Arnold M, Engelter ST, Lyrer P, CADISP-Plus Study Group (2019). Artery occlusion independently predicts unfavorable outcome in cervical artery dissection. Neurology, 94(2), e170-e180. (Read full article)
    36. de Havenon A, Chung LS, Smith J, Taylor K, Majersik JJ, Chauhan N (2019). Less Experienced Telestroke Consultants Are More Likely to Go On-Camera, but Less Likely to Give tPA. Stroke Res Treat, 2019, 1059369. (Read full article)
    37. de Havenon A, Fino NF, Johnson B, Wong KH, Majersik JJ, Tirschwell D, Rost N (2019). Blood Pressure Variability and Cardiovascular Outcomes in Patients With Prior Stroke: A Secondary Analysis of PRoFESS. Stroke, 50(11), 3170-3176. (Read full article)
    38. de Havenon A, Wong KH, Elkhetali A, McNally JS, Majersik JJ, Rost NS (2019). Carotid Artery Stiffness Accurately Predicts White Matter Hyperintensity Volume 20 Years Later: A Secondary Analysis of the Atherosclerosis Risk in the Community Study. AJNR Am J Neuroradiol, 40(8), 1369-1373. (Read full article)
    39. Majersik JJ (2019). Ethics and Bias in Clinical Trial Enrollment in Stroke. Curr Cardiol Rep, 21(6), 49. (Read full article)
    40. Touz E, Southerland AM, Boulanger M, Labeyrie PE, Azizi M, Bouatia-Naji N, Debette S, Gornik HL, Hussain SM, Jeunemaitre X, Joux J, Kirton A, Le Hello C, Majersik JJ, Mocco J, Persu A, Sharma A, Worrall BB, Olin JW, Plouin PF (2018). Fibromuscular Dysplasia and Its Neurologic Manifestations: A Systematic Review. JAMA Neurol, 76(2), 217-226. (Read full article)
    41. de Havenon A, Tirschwell D, Majersik JJ, McNally S, Stoddard G, Moore A, Mossa-Basha M (2017). Carotid intraplaque hemorrhage on vessel wall MRI does not correlate with TCD emboli monitoring in patients with recently symptomatic carotid atherosclerosis. Neuroradiol J, 30(5), 486-489. (Read full article)
    42. McNally JS, Burton TM, Aldred BW, Kim SE, McLaughlin MS, Eisenmenger LB, Stoddard GJ, Majersik JJ, Miller DV, Treiman GS, Parker DL (2016). Vitamin D and Vulnerable Carotid Plaque. AJNR Am J Neuroradiol, 37(11), 2092-2099. (Read full article)
    43. Nelson RE, Okon N, Lesko AC, Majersik JJ, Bhatt A, Baraban E (2015). The cost-effectiveness of telestroke in the Pacific Northwest region of the USA. J Telemed Telecare, 22(7), 413-21. (Read full article)
    44. Sangle N, Baringer JR, Majersik J, DeWitt LD (2015). CADASIL with Multiorgan Involvement: a Complete Autopsy Examination Report. Can J Neurol Sci, 43(1), 202-5. (Read full article)
    45. de Havenon A, Moore A, Sultan-Qurraie A, Majersik JJ, Stoddard G, Tirschwell D (2015). Ischemic stroke patients with active malignancy or extracardiac shunts are more likely to have a right-to-left shunt found by TCD than echocardiogram. Transl Stroke Res, 6(5), 361-4. (Read full article)
    46. Sardar P, Chatterjee S, Giri J, Kundu A, Tandar A, Sen P, Nairooz R, Huston J, Ryan JJ, Bashir R, Parikh SA, White CJ, Meyers PM, Mukherjee D, Majersik JJ, Gray WA (2015). Endovascular therapy for acute ischaemic stroke: a systematic review and meta-analysis of randomized trials. Eur Heart J, 36(35), 2373-80. (Read full article)
    47. Debette S, Compter A, Labeyrie MA, Uyttenboogaart M, Metso TM, Majersik JJ, Goeggel-Simonetti B, Engelter ST, Pezzini A, Bijlenga P, Southerland AM, Naggara O, Bjot Y, Cole JW, Ducros A, Giacalone G, Schilling S, Reiner P, Sarikaya H, Welleweerd JC, Kappelle LJ, de Borst GJ, Bonati LH, Jung S, Thijs V, Martin JJ, Brandt T, Grond-Ginsbach C, Kloss M, Mizutani T, Minematsu K, Meschia JF, Pereira VM, Bersano A, Touz E, Lyrer PA, Leys D, Chabriat H, Markus HS, Worrall BB, Chabrier S, Baumgartner R, Stapf C, Tatlisumak T, Arnold M, Bousser MG (2015). Epidemiology, pathophysiology, diagnosis, and management of intracranial artery dissection. Lancet Neurol, 14(6), 640-54. (Read full article)
    48. Walker KA, Sampson JB, Skalabrin EJ, Majersik JJ (2013). Clinical characteristics and thrombolytic outcomes of infective endocarditis-associated stroke. Neurohospitalist, 2(3), 87-91. (Read full article)
    49. Nelson RE, Saltzman GM, Skalabrin EJ, Demaerschalk BM, Majersik JJ (2011). The cost-effectiveness of telestroke in the treatment of acute ischemic stroke. Neurology, 77(17), 1590-8. (Read full article)
    50. Cantu-Brito C, Majersik JJ, Snchez BN, Ruano A, Becerra-Mendoza D, Wing JJ, Morgenstern LB (2011). Door-to-door capture of incident and prevalent stroke cases in Durango, Mexico: the Brain Attack Surveillance in Durango Study. Stroke, 42(3), 601-6. (Read full article)
    51. Arsava EM, Ballabio E, Benner T, Cole JW, Delgado-Martinez MP, Dichgans M, Fazekas F, Furie KL, Illoh K, Jood K, Kittner S, Lindgren AG, Majersik JJ, Macleod MJ, Meurer WJ, Montaner J, Olugbodi AA, Pasdar A, Redfors P, Schmidt R, Sharma P, Singhal AB, Sorensen AG, Sudlow C, Thijs V, Worrall BB, Rosand J, Ay H, International Stroke Genetics Consortium (2010). The Causative Classification of Stroke system: an international reliability and optimization study. Neurology, 75(14), 1277-84. (Read full article)
    52. Meurer WJ, Scott PA, Caveney AF, Majersik JJ, Frederiksen SM, Sandretto A, Holden AB, Silbergleit R (2010). Lack of association between hyperglycaemia at arrival and clinical outcomes in acute stroke patients treated with tissue plasminogen activator. Int J Stroke, 5(3), 163-6. (Read full article)
    53. Cantu-Brito C, Majersik JJ, Snchez BN, Ruano A, Quiones G, Arzola J, Morgenstern LB (2010). Hospitalized stroke surveillance in the community of Durango, Mexico: the brain attack surveillance in Durango study. Stroke, 41(5), 878-84. (Read full article)
    54. Mullen Conley K, Juhl Majersik J, Gonzales NR, Maddox KE, Pary JK, Brown DL, Moye LA, Espinosa N, Grotta JC, Morgenstern LB (2010). Kids Identifying and Defeating Stroke (KIDS): development and implementation of a multiethnic health education intervention to increase stroke awareness among middle school students and their parents. Health Promot Pract, 11(1), 95-103. (Read full article)
    55. Lisabeth LD, Brown DL, Hughes R, Majersik JJ, Morgenstern LB (2009). Acute stroke symptoms: comparing women and men. Stroke, 40(6), 2031-6. (Read full article)
    56. Brown DL, Zahuranec DB, Majersik JJ, Wren PA, Gruis KL, Zupancic M, Lisabeth LD (2009). Risk of sleep apnea in orchestra members. Sleep Med, 10(6), 657-60. (Read full article)
    57. Meurer WJ, Snchez BN, Smith MA, Lisabeth LD, Majersik JJ, Brown DL, Uchino K, Bonikowski FP, Mendizabal JE, Zahuranec DB, Morgenstern LB (2008). Predicting ischaemic stroke subtype from presenting systolic blood pressure: the BASIC Project. J Intern Med, 265(3), 388-96. (Read full article)
    58. Lisabeth LD, Escobar JD, Dvonch JT, Snchez BN, Majersik JJ, Brown DL, Smith MA, Morgenstern LB (2008). Ambient air pollution and risk for ischemic stroke and transient ischemic attack. Ann Neurol, 64(1), 53-9. (Read full article)
    59. Majersik JJ, Silbergleit R, Meurer WJ, Brown DL, Lisabeth LD, Morgenstern LB (2008). Public health impact of full implementation of therapeutic hypothermia after cardiac arrest. Resuscitation, 77(2), 189-94. (Read full article)
    60. Brown DL, Morgenstern LB, Majersik JJ, Kleerekoper M, Lisabeth LD (2008). Risk of fractures after stroke. Cerebrovasc Dis, 25(1-2), 95-9. (Read full article)
    61. Lisabeth LD, Peyser PA, Long JC, Majersik JJ, Smith MA, Morgenstern LB (2008). Stroke Among Siblings in a Bi-ethnic Community. Neuroepidemiology, 31, 33-38.
    62. Majersik JJ, Smith MA, Zahuranec DB, Snchez BN, Morgenstern LB (2007). Population-based analysis of the impact of expanding the time window for acute stroke treatment. Stroke, 38(12), 3213-7. (Read full article)
    63. Meurer WJ, Frederiksen SM, Majersik JJ, Zhang L, Sandretto A, Scott PA (2007). Qualitative data collection and analysis methods: the INSTINCT trial. Acad Emerg Med, 14(11), 1064-71. (Read full article)
    64. Majersik JJ, Caravati EM, Steffens JD (2007). Severe neurotoxicity associated with exposure to the solvent 1-bromopropane (n-propyl bromide). Clin Toxicol (Phila), 45(3), 270-6. (Read full article)
    65. Pribble JM, Goldstein KM, Majersik JJ, Barsan WG, Brown DL, Morgenstern LB (2006). Stroke information reported on local television news: a national perspective. Stroke, 37(6), 1556-7. (Read full article)
    66. Majersik JJ, Skalabrin EJ (2006). Single-gene stroke disorders. Semin Neurol, 26(1), 33-48. (Read full article)

    Review

    1. Schliep KC, Mclean H, Yan B, Qeadan F, Theilen LH, de Havenon A, Majersik JJ, stbye T, Sharma S, Varner MW (2022). Association Between Hypertensive Disorders of Pregnancy and Dementia: a Systematic Review and Meta-Analysis. [Review]. Hypertension, 80(2), 257-267. (Read full article)
    2. DiBella EVR, Sharma A, Richards L, Prabhakaran V, Majersik JJ, HashemizadehKolowri SK (2022). Beyond Diffusion Tensor MRI Methods for Improved Characterization of the Brain after Ischemic Stroke: A Review. [Review]. AJNR Am J Neuroradiol, 43(5), 661-669. (Read full article)

    Book Chapter

    1. Southerland A, Majersik JJ, Worrall BB (04/29/2015). Chapter 15: Cervical Artery Dissection. In Gilbert R. Upchurch Jr., Peter K. Henke (Eds.), Clinical Scenarios in Vascular Surgery, Second Edition. LWW.

    Editorial

    1. Majersik JJ, Lacaze P (2022). Common Genetic Variants and Early Onset Stroke: Clues but No Answers. Neurology. (Read full article)
    2. Garcia-Esperon C, Majersik JJ (2022). Taking the Eyes of the Stroke Neurologist to the Ambulance: The Kiwi Experience. Neurology. (Read full article)
    3. Muir KW, Majersik JJ (2021). Connecting Upper Limb Functional Stroke Recovery to Global Disability Measures: Finding the Forest in the Trees. Neurology, 96(14), 643-644. (Read full article)
    4. Majersik JJ, Woo D (2020). The enormous financial impact of stroke disability. Neurology, 94(9), 377-378. (Read full article)
    5. Majersik JJ (2015). Doctor, did stress cause my stroke? Neurology, 85(19), 1640-1. (Read full article)
    6. Majersik JJ, Schmidt RH (2015). Continued risk of SAH after negative screen in first-degree relatives--and persistent questions. Neurology, 84(9), 868-9. (Read full article)
    7. Majersik JJ, Schmidt RH (03/03/2015). Continued risk of SAH after negative screen in first degree relatives - and persistent questions. Invited editorial on Rasing I, et al. Longterm risk of subarachnoid hemorrhage after a negative aneurysm screen. Neurology, 84(9), 868-9.

    Letter

    1. Richard JV, Mehrotra A, Schwamm LH, Wilcock AD, Uscher-Pines L, Majersik JJ, Zachrison KS (2022). Improving Population Access to Stroke Expertise Via Telestroke: Hospitals to Target and the Potential Clinical Benefit. [Letter to the editor]. J Am Heart Assoc, 11(8), e025559. (Read full article)

    Abstract

    1. McNally JS, Aldred B, Burton T, McLauglin M, Kim S, Miller D, Majersik J, Parker D, Treiman G (2015). Vitamin D and Vulnerable Carotid Plaque. Accepted for oral presentation at the American Society of Neuroradiology, Chicago, USA, 2015. [Abstract]. AJNR.
    2. de Havenon A, Stoddard G, Wang H, Chung L, Majersik JJ (May 2015). Increased blood pressure variable is associated with worse outcome in acute ischemic stroke patients with penumbra. Accepted for oral presentation at the European Stroke Conference, Vienna, Austria, May 2015. [Abstract]. Cerebrovascular Diseases.
    3. Krug A, Ramirez L, Nhoung H, Perese J, Gasparian G, Kazaryan S, Kelly C, Breen J, Majersik JJ, Sanossian N (02/12/2015). A Survey of Certified Stroke Center Medical Directors in the United States. Poster Board Number: P283. Accepted as a poster to the International Stroke Conference, February 11-13, 2015, Nashville, TN, USA [Abstract]. Stroke.
    4. Nelson R, Lesko A, Majersik J, Okon N, Bhatt A, Baraban E (2/12/2015). Budget Impact Analysis of Telestroke in the Pacific Northwest, Abstract, # 3732. Accepted for poster presentation at the International Stroke Conference February 11 - 13, 2015, Nashville, TN, USA [Abstract]. Stroke.
    5. Okon N, Nelson R, Majersik J, Lesko A, Bhatt A, Baraban E (2/11/2015). Telestroke Network Cost-Effectiveness in the Pacific Northwest: Geography and Facility Size Support a Cost-Sharing Model Between Hub and Spoke, Abstract #3176. Accepted as a moderated poster presentation to the International Stroke Conference, February 11 - 13, 2015, Nashville, TN, USA. [Abstract]. Stroke.
    6. Baraban E, Nelson R, Lesko A, Majersik J, Bhatt A, Okon (2/11/2015). The Cost-Effectiveness of Telestroke Varies by Implementation Cost and Stroke Severity: Real World Data From a Pacific Northwest Network, Abstract # 3665. ccepted for poster presentation at the International Stroke Conference, February 11 - 13, 2015, Nashville, TN, USA [Abstract]. Stroke.
    7. Majersik JJ, Cannon-Albright L (2012). Large Pedigrees at High Risk of Early Stroke Death [Abstract].
    8. Majersik JJ, Jex RF, Skalabrin EJ, Taillac PP (May 2012). Development and Initial Results of an Inclusive State-Wide Approach to Stroke Care [Abstract]. Quality Care and Outcomes Research in Cardiovascular Disease and Stroke 2012 Scientific Sessions, Atlanta, GA.
    9. Southerland AM, Malik S, Majersik JJ, Worrall BB (2/1/2011). Age Distribution by Sex and Clinical Characteristic in Cervical Artery Dissection. Presented in poster form at the American Academy of Neurology annual meeting, Honolulu, HI, USA [Abstract].
    10. Majersik JJ, Cannon-Albright LA (2010). Evidence for a Heritable Contribution to Death from Ischemic Stroke. American Academy of Neurology, Toronto, Canada. [Abstract].
    11. Nelson RE, Saltzman G, Skalabrin EJ, Majersik JJ (2010). Cost-Effectiveness of Telestroke for Ischemic Stroke: A Literature-Based Decision-Analytic Model. International Stroke Conference, San Antonio, TX, USA [Abstract].
    12. Cantu CB, Majersik JJ, Sanchez BS, Morgenstern LB (2009). Physician Perception of Acute Stroke Care in a Mexican Community, American Academy of Neurology, Seattle, WA, USA. [Abstract].